Semax, An ACTH(4-10) Analogue with Nootropic Properties, Activates Dopaminergic and Serotoninergic Brain Systems in Rodents
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Corticotrophin (ACTH) and its analogues, particularly Semax (Met-Glu-His-Phe-Pro-Gly-Pro), demonstrate nootropic activity. Close functional and anatomical links have been established between melanocortinergic and monoaminergic brain systems. The aim of present work was to investigate the effects of Semax on neurochemical parameters of dopaminergic- and serotonergic systems in rodents. The tissue content of 5-hydroxyindoleacetic acid (5-HIAA) in the striatum was significantly increased (+25%) 2 h after Semax administration. The extracellular striatal level of 5-HIAA gradually increased up to 180% within 1-4 h after Semax (0.15 mg/kg, ip) administration. This peptide alone failed to alter the tissue and extracellular concentrations of dopamine and its metabolites. Semax injected 20 min prior D: -amphetamine dramatically enhanced the effects of the latter on the extracellular level of dopamine and on the locomotor activity of animals. Our results reveal the positive modulatory effect of Semax on the striatal serotonergic system and the ability of Semax to enhance both the striatal release of dopamine and locomotor behavior elicited by D-amphetamine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Decreased serum brain-derived neurotrophic factor levels in major depressed patients
Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., & Aubry, J.-M. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00005-7 · Cited by 1,232 · cited 1×
“The clinical studies have also suggested that a decreased level of BDNF may be involved in the pathogenesis of the major depressive disorder (38,39).”
Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat
Kishi, T., Aschkenasi, C. J., Lee, C. E., Mountjoy, K. G., Saper, C. B., & Elmquist, J. K. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10454 · Cited by 581
Dopamine: a potential substrate for synaptic plasticity and memory mechanisms
Jay, T. M. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00085-6 · Cited by 577
Role of Neurotrophic Factors in the Etiology and Treatment of Mood Disorders
Duman, R. S. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:011 · Cited by 537
Critical Role of Brain-Derived Neurotrophic Factor in Mood Disorders
Hashimoto, K., Shimizu, E., & Iyo, M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.02.003 · Cited by 522
de Wied, D. (1966) · Experimental Biology and Medicine · doi:10.3181/00379727-122-31042 · Cited by 256
Clinical role of brain-derived neurotropic factor in mood disorders
Hashimoto, K. (2004) · Medical Entomology and Zoology · Cited by 183
Blöchl, A., & Sirrenberg, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21100 · Cited by 182
Research works printed but not linked: 5
- A. Witter, 1975, J. Pharmacol. Exp. Ther., 193, 853
- F. L. Strand, 2003, Prog. Drug Res., 61, 1
- I. P. Asmarin, 1997, Zh. Vyssh. Nerv. Deiat. Im. I. P. Pavlova, 47, 420
- I. P. Ashmarin, 1995, Neurosci. Res. Commun., 16, 105
- W. J. Florijn, 1992, J. Pharmacol. Exp. Ther., 263, 787
Cited by
An update on pharmacological approaches to neurodegenerative diseases
Scatena, R., Martorana, G. E., Bottoni, P., Botta, G., Pastore, P., & Giardina, B. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.1.59 · Cited by 66
“This corticotropin fragment afforded the improvement of neurochemical parameters of dopamine- and 5-HT-mediated systems, enhancing both the striatal release of dopamine and the locomotor behaviour with positive symptomatic effects in different neurodegenerative processes [96].”
BackgroundA New Generation of Drugs: Synthetic Peptides Based on Natural Regulatory Peptides
Kolomin, T., Shadrina, M., Slominsky, P., Limborska, S., & Myasoedov, N. (2013) · Neuroscience and Medicine · doi:10.4236/nm.2013.44035 · Cited by 30
“A positive modulator effect of Semax on the serotoninergic system of the striatum was also shown [84], with reduction of nociception [85] and normalization of the circadian locomotor rhythms [86].”
Self-citationFilippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Sudarkina, O. Y., Dmitrieva, V. G., Gubsky, L. V., Myasoedov, N. F., Limborska, S. A., et al. (2020) · Genes · doi:10.3390/genes11060681 · Cited by 29
Self-citationLevitskaya, N. G., Vilensky, D. A., Sebentsova, E. A., Андреева, Л. А., Kamensky, A. A., & Myasoedov, N. F. (2010) · Biology Bulletin · doi:10.1134/s1062359010020147 · Cited by 21
Self-citationShadrina, M. I., Kolomin, T. A., Agapova, T. M., Agniullin, Y., Shram, S. I., Slominsky, P. A., Lymborska, S., & Myasoedov, N. F. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9270-z · Cited by 22
Self-citationNeuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease
Khavinson, V. K., Ilina, A., Kraskovskaya, N., Linkova, N. S., Колчина, Н. В., Mironova, E. S., Erofeev, A., & Petukhov, M. (2021) · Pharmaceuticals · doi:10.3390/ph14060515 · Cited by 20
“This concentration and method of administration of the peptides were chosen based on the analysis of the literature [77] and preliminary experiments.”
Sudarkina, O. Y., Filippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Valieva, L. V., Remizova, J. A., Dmitrieva, V. G., Gubsky, L. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126179 · Cited by 15
“Being a synthetic derivative of natural melanocortins, Semax exhibits several of the important neuroprotective properties of α-MSH: it potentiates dopamine and serotoninergic transmission in the striatum [10], exerts neurotrophic effects in primary neuronal cultures [11], and promotes the survival of neurons under con…”
BackgroundSelf-citationThe Melanocortin System: A Promising Target for the Development of New Antidepressant Drugs
Markov, D. D., Dolotov, O. V., & Grivennikov, I. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076664 · Cited by 14
“15 mg/kg IP Extracellular striatal level of 5-HIAA ↑ [71]”
BackgroundSelf-citationTsai, S. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.07.017 · Cited by 10
“A recent animal study showed that Semax alone failed to alter tissue and extracellular concentrations of dopamine, however, Semax injected 20 min prior to dextroamphetamine administration dramatically increased the effects of the latter on extracellular dopamine levels [17].”
Glazova, N. Y., Манченко, Д. М., Volodina, M. A., Merchieva, S. A., Andreeva, L. A., Кудрин, В. С., Myasoedov, N. F., & Levitskaya, N. G. (2020) · Neuropeptides · doi:10.1016/j.npep.2020.102114 · Cited by 10
Self-citationZhuikova, S. E. (2022) · Integrative Physiology · doi:10.33910/2687-1270-2022-3-2-204-220 · Cited by 5
Semax corrects brain dysfunction caused by prenatal introduction of valproic acid
Малышев, А. В., Razumkina, E. V., Дубынин, В. А., & Myasoedov, N. F. (2013) · Doklady Biological Sciences · doi:10.1134/s0012496613030046 · Cited by 3
Self-citationHavrylov, I., & Shtrygol’, S. (2021) · Česká a slovenská farmacie · doi:10.5817/csf2021-3-91 · Cited by 8
Agapova, T. Y., Agniullin, Y. V., Silachev, D. N., Shadrina, M. I., Slominsky, P. A., Shram, S. I., Limborskaya, S. A., & Myasoedov, N. F. (2007) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672907060129 · Cited by 4
Self-citationРегуляторные пептиды семейства меланокортинов: биосинтез, рецепция, биологические эффекты
Dodonova, S. A., Белых, А. Е., & Бобынцев, И. И. (2018) · Человек и его здоровье · doi:10.21626/vestnik/2018-1/15 · Cited by 6
Saleh, A. Y., Saputra, D. A. Y., Valentina, R., & Susanto, T. D. (2025) · F1000Research · doi:10.12688/f1000research.160416.3 · Cited by 4
Effects of neonatal fluvoxamine administration to white rats and their correction by semax treatment
Volodina, M. A., Merchieva, S. A., Sebentsova, E. A., Glazova, N. Y., Манченко, Д. М., Андреева, Л. А., Levitskaya, N. G., Kamensky, A. A., & Myasoedov, N. F. (2014) · Biology Bulletin · doi:10.1134/s106235901403011x · Cited by 3
“Previously it was shown that semax increases the content of serotonin and its metabolite in the brain; i.e., it increases the functional activity of the serotonergic system in the brain (Eremin et al., 2005).”
BackgroundSelf-citationЯсенявская, А. Л., Самотруева, М. А., Мясоедов, Н. Ф., et al. (2019) · Человек и его здоровье · doi:10.21626/vestnik/2019-2/06 · Cited by 3
Effects of semax on the activity of carboxypeptidase H in brain regions and adrenal glands of rats
Solov’ev, V. B., Генгин, М. Т., Sollertinskaya, T. N., Владимировна, Л. И., & Владимировна, Ж. Л. (2011) · Neurochemical Journal · doi:10.1134/s1819712411020115 · Cited by 2
Agapova, T. Y., Agniullin, Y. V., Silachev, D. N., Shadrina, M. I., Slominsky, P. A., Shram, S. I., Limborskaya, S. A., & Myasoedov, N. F. (2008) · Molecular Genetics Microbiology and Virology · doi:10.3103/s0891416808030063 · Cited by 3
Self-citationA possible role of transthyretin in the biological mechanism of regulatory peptide neuroprotection
V’yunova, T. V., Medvedeva, E. V., Андреева, Л. А., Dergunova, L. V., Limborska, S. A., & Myasoedov, N. F. (2016) · Molecular Genetics Microbiology and Virology · doi:10.3103/s0891416816030101 · Cited by 3
Self-citationYasenyavskaya, A. L., Самотруева, М. А., Myasoedov, N. F., et al. (2022) · European Pharmaceutical Journal · doi:10.2478/afpuc-2022-0004 · Cited by 1
Self-citationPeng, J., Qi, J., Yu, X., et al. (2025) · Measurement Science and Technology · doi:10.1088/1361-6501/adcada · Cited by 1
Budkevich, R. O., Evdokimov, I. A., & Budkevich, E. V. (2012) · CyberLeninK (CyberLeninka) · Cited by 1
Possible role of transthyretin in the biological mechanism of the regulatory peptide neuroprotection
V’yunova, T. V., Medvedeva, E. V., Андреева, Л. А., Dergunova, L. V., Limborska, S. A., & Myasoedov, N. F. (2016) · Molecular Genetics Microbiology and Virology (Russian) · doi:10.18821/0208-0613-2016-34-3-104-109 · Cited by 2
Self-citationFilatova, E. V., Shadrina, M. I., Kolomin, T. A., Andreeva, L. A., Myasoedov, N. F., & Slominsky, P. A. (2016) · World Journal of Neuroscience · doi:10.4236/wjns.2016.64030
Self-citationSaleh, A. Y., Saputra, D. A. Y., Valentina, R., & Susanto, T. D. (2025) · F1000Research · doi:10.12688/f1000research.160416.1 · Cited by 1
Kolbaev, S. N., Sharonova, I. N., & Skrebitsky, V. G. (2025) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-025-06501-z
Metadata
- Authors
- Eremin, K. O., Kudrin, V. S., Saransaari, P., Oja, S. S., Grivennikov, I. A., Myasoedov, N. F., & Rayevsky, K. S.
- Affiliations
- University of Tampere (FI)
- Tampere University Hospital (FI)
- Institute of Molecular Genetics (RU)
- Institute of Pharmacology Russian Academy of Medical Sciences (RU)
- ORCID
- Grivennikov, Igor A.
- Venue
- Neurochemical Research
- Published
- 2005-12
- Volume
- 30
- Issue
- 12
- Pages
- 1493-1500
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- OpenAlex
- W2016846216
- Cited by
- 29
- References
- 40
- Citations by year
- 2025: 5 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 1 · 2016: 3 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 0.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Semax, nootropic activity, dopaminergic system, serotonergic system, 5-hydroxyindoleacetic acid, striatum, dopamine release, d-amphetamine, locomotor activity, monoaminergic systems, extracellular neurotransmitter levels
- MeSH terms
- Adrenocorticotropic Hormone, Animals, Corpus Striatum, Dextroamphetamine, Dopamine, Hydroxyindoleacetic Acid, Male, Mice, Inbred C57BL, Motor Activity, Peptide Fragments, Serotonin Receptor Agonists, Dopamine Agonists, Nootropic Agents, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.